(Press-News.org)
A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit from new drugs.
The findings were published today in Nature Immunology and validated in both mouse models and humans.
“We think we have uncovered a potential biomarker that signals a patient is experiencing so-called ‘compartmentalized inflammation’ in the central nervous system, a phenomenon which is strongly liked to MS progression,” says Jen Gommerman, a professor and chair of immunology at U of T’s Temerty Faculty of Medicine. “It’s been really hard to know who is progressing and who isn’t.”
Canada has one of the highest rates of MS in the world with over 4,300 Canadians diagnosed with the condition each year, according to MS Canada.
Roughly 10 per cent of people with MS are initially diagnosed with progressive MS, which leads to a gradual worsening of symptoms and increasing disability over time. Patients initially diagnosed with relapsing-remitting MS, the more common form of the condition, can also go on to develop progressive MS.
“We have immunomodulatory drugs that can modulate the relapsing and remitting phase of the disease,” says Valeria Ramaglia, a scientist at the University Health Network’s Krembil Brain Institute and an assistant professor of immunology at Temerty Medicine.
“But for progressive MS, the landscape is completely different. We have no effective therapies.”
Ramaglia, who co-led the study with Gommerman, notes that until their study, the research field did not have a good model that replicates the pathology of progressive MS.
To understand the mechanisms driving progressive MS, the researchers developed a new mouse model that mimics the damage in the brain’s grey matter seen in people with progressive MS. A hallmark of this so-called grey matter injury is compartmentalized inflammation in the leptomeninges, a thin plastic wrap-like membrane that encases the brain and spinal cord.
Using their mouse model, they also observed a roughly 800-fold increase in an immune signal called CXCL13 and significantly lower levels of another immune protein called BAFF.
By treating these mice with BTK inhibitor drugs — which are currently being tested in clinical trials to target progressive MS — the researchers mapped out a circuit in the brain that led to grey matter injury and inflammation. They also found that BTK inhibitors restored CXCL13 and BAFF levels to those seen in healthy mice.
These results led the researchers to hypothesize that the ratio of CXCL13 to BAFF could be a surrogate marker for leptomeningeal inflammation.
To test the validity of their findings in humans, the researchers measured the CXCL13-to-BAFF ratio in postmortem brain tissues from people who had MS and in the cerebrospinal fluid of a living cohort of people with MS. In both cases, a high CXCL13-to-BAFF ratio was associated with greater compartmentalized inflammation in the brain.
Thus far, BTK inhibitors have seen mixed results in clinical trials with people with MS. Ramaglia says that without an easy way to detect leptomeningeal inflammation, the trials likely enrolled participants who did not have this feature and were unlikely to benefit from the drug. Any positive results from people with compartmentalized inflammation would then be diluted.
“If we can use the ratio as a proxy to tell which patients should be treated with a drug that targets leptomeningeal inflammation, that can revolutionize the way we do clinical trials and how we treat patients,” says Ramaglia.
As she builds her own research program at the Krembil Brain Institute, Ramaglia is continuing to collaborate with Gommerman to explore how the CXCL13-to-BAFF ratio can be used to advance precision medicine for people with MS. They are working with the pharmaceutical companies behind the BTK inhibitor trials to look at whether the participants who responded the most to the drugs also had high ratios of CXCL13 to BAFF.
Ramaglia is also planning to look at CXCL13 and BAFF levels in people with early MS to see if it can predict who is likely to develop progressive MS later.
She credits her time as a research associate in Gommerman’s lab as playing a key role in helping her become an independent investigator.
“Jen’s lab was a huge stepping stone for me. She gave me the space and independence to build my own research.”
This research was supported by the Canadian Institutes of Health Research, MS Canada, the National Multiple Sclerosis Society and the United States Department of Defense.
END
In a new study, Christine Agdestein has surveyed several aspects of the postnatal check-up. Agdestein is a specialist in general practice and a general practitioner, and is currently a PhD candidate at the Norwegian University of Science and Technology (NTNU). The research project is part of her PhD.
"An important finding is that the majority are satisfied with the 6-week check-up with their GP. This is an important offer for those who have recently given birth. GPs have an important role in postnatal care," says Christine Agdestein.
"Not much research has been done on the postnatal check-up before, and therefore it is extra rewarding that we can ...
Quick clay is actually an old seabed. The clay thus formed under water, but came to the surface when the landscape rose after the last ice age.
However, this clay was not so dangerous, because it was full of salt from the sea. Only when the salt in the clay was washed out of fresh water from rain and groundwater did it turn into quick clay.
But what exactly makes quick clay so unstable?
"We have made very detailed and careful simulations of the friction between clay particles," says researcher and doctor Ge Li at PoreLab and the Department of Mechanical Engineering and Production at the Norwegian University of Science ...
When quantum particles work together, they can produce signals far stronger than any one particle could generate alone. This collective phenomenon, called superradiance, is a powerful example of cooperation at the quantum level. Until now, superradiance was mostly known for making quantum systems lose their energy too quickly, posing challenges for quantum technologies. But a new study published in Nature Physics turns this idea on its head— revealing that collective superradiant effects ...
Cleveland: Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why immunotherapy works for some patients but not others.
Two new studies, published simultaneously in Nature Cancer, reveal that elevated levels of bacteria in the tumor microenvironment suppress immune response, driving resistance to immunotherapy in patients with head and neck squamous cell carcinoma.
“These studies shift the focus of immunotherapy resistance research beyond tumor genetics ...
The first Editorial of the year at Science always gives the Editor-in-Chief an opportunity to reflect on notable developments for the Science journals. In this Editorial, Holden Thorp focuses on AI, discussing how it “will allow the scientific community to do more if it picks the right ways to use it.” He revisits the journals’ policies and approaches related to AI. The journals do use select AI tools. Over the past year for example, Science has collaborated with DataSeer to evaluate adherence to its policy mandating the sharing of underlying data and code for all published ...
Simultaneous ground- and space-based observations of a newly discovered free-floating planet have enabled direct measurement of its mass and distance from Earth, according to a new study. The findings offer insights into the diverse and dynamic pathways by which planets can be cast adrift into interstellar space. Although studies to date have only revealed a handful of such free-floating planets, detections are expected to increase in the coming years, particularly with the NASA Nancy Grace Roman Space Telescope campaign that is scheduled for launch in 2027, ...
A newly identified and rare genetic variant slows the growth of mutated blood stem cells, researchers report, and it reduces the risk of leukemia. The findings offer insight into why some people are naturally more resistant to clonal expansion and age-related blood cancers despite acquiring risky mutations. As tissues age, they quietly accumulate many mutations that can drive cancer. In the blood-forming, or hematopoietic, system, such mutations often appear in otherwise healthy individuals as clonal hematopoiesis (CH), a process in which certain blood stem cell (HSC) ...
Pigs across the Pacific can trace their ancestry to Southeast Asian domestic pigs that accompanied early Austronesian-speaking groups as they island-hopped across the region, according to a new genomic study. For thousands of years, humans have moved animals far beyond their natural ranges – sometimes accidentally and sometimes deliberately, but often with profound ecological consequences, especially on islands. Pigs are a striking example; although their home ranges lie mostly west of the Wallace Line, multiple species are now widespread across the islands of Southeast Asia and throughout Oceania. Archaeological and genetic evidence suggest that pigs ...
A new study shows that coral reefs don’t just provide a home for ocean life, they also help set the daily “schedule” for tiny microbes living in the water nearby. Over the course of a single day, the quantity and types of microbes present can shift dramatically. To see this in detail, researchers took frequent water samples and used a mix of genetic and ecological methods and tools, as well as advanced imaging techniques, to track what was happening hour by hour. They found that reefs can shape microbial communities ...
Researchers working on China's fully superconducting Experimental Advanced Superconducting Tokamak (EAST) have experimentally accessed a theorized "density-free regime" for fusion plasmas, achieving stable operation at densities well beyond conventional limits. The results, reported in Science Advances on January 1, provide new insights into overcoming one of the most persistent physical obstacles on the path toward nuclear fusion ignition.
The study was co-led by Prof. ZHU Ping from Huazhong University of Science and Technology and Associate Prof. YAN Ning from the Hefei Institutes of Physical Science ...
